JournalTOCs

Publisher: Thomson Reuters (Total: 1 journals) [Sort by number of followers]

Showing 1 - 1 of 1 Journals sorted alphabetically
	Drugs of the Future (Followers: 7, SJR: 0.127, CiteScore: 0)

Most Followed Journals

Top Publishers

Top Subjects

Similar Journals

Drugs of the Future
Journal Prestige (SJR): 0.127

Number of Followers: 7

Full-text available via subscription

Subscription journal
ISSN (Print) 0377-8282
Published by Thomson Reuters

[1 journal]

Belantamab mafodotin for the treatment of multiple myeloma.
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  First page: 653
  PubDate: 2021-12-07T23:20:50-05:00
  Issue No: Vol. 57, No. 11 (2021)
Isatuximab for the treatment of multiple myeloma.
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  First page: 665
  PubDate: 2021-12-07T23:20:50-05:00
  Issue No: Vol. 57, No. 11 (2021)
Naxitamab: a humanized anti-glycolipid disialoganglioside (anti-GD2)
monoclonal antibody for treatment of neuroblastoma.
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  First page: 677
  PubDate: 2021-12-07T23:20:50-05:00
  Issue No: Vol. 57, No. 11 (2021)
Aflibercept, ranibizumab and bevacizumab upcoming biosimilars: a general
overview.
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  First page: 689
  PubDate: 2021-12-07T23:20:50-05:00
  Issue No: Vol. 57, No. 11 (2021)
New product intros [ADV-7103 (new combination), asparaginase Erwinia
chrysanthemi, empagliflozin (new indication), MVC-COV-1901, ON-101,
penpulimab, ponesimod, sotorasib, upacicalcet sodium hydrate, upadacitinib
tartrate (new indication), zimberelimab, ZyCoV-D].
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  First page: 699
  PubDate: 2021-12-07T23:20:50-05:00
  Issue No: Vol. 57, No. 11 (2021)